Novel approved for yet another drug (LEVONORGESTREL (ANDA) 202508)
Billion dollar blockbuster drug INTERMEZZO approved for generics, and Novel is currently development.
Elite's 10% of Novel Labs is worth at least $50 mil. Any type of financing effort by Elite for their human trials will definitely be from the monetization of the Novel investment. This stock is worth like 50 cents right now. Anyone scooping up shares at these penny levels realizes that Elite is not updating shareholders with current valuations of their Novel investment, nor their strategic alliances with other companies and product development, due to 'competitive reasons'. its like a dream come true stock for investors willing to put in the due diligence - no brainer to realize this stock will be at dollar levels very soon.
As far as Novel Labs go, here is their latest list of approved drugs, and now add to that the LEVONORGESTREL.